A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED 12-WEEK TRIAL OF EPLIVANSERIN IN INSOMNIAC PATIENTS WITH SLEEP MAINTENANCE DIFFICULTIES

被引：0

作者：

Erman, M. ^{[1
]}

Kryger, M. ^{[2
]}

Soubrane, C. ^{[3
]}

Morin, C. ^{[4
]}

Hajak, G. ^{[5
]}

机构：

[1] Pacific Sleep Med Res, San Diego, CA USA

[2] Gaylord Hosp, Wallingford, CT USA

[3] Sanofi Aventis Rech & Dev, Chilly Mazarin, France

[4] Univ Laval, Ste Foy, PQ, Canada

[5] Klin & Poliklin Psychiat & Psychotherapie, Regensburg, Germany

来源：

SLEEP | 2009年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

121

引用

页码：A41 / A41

页数：1

共 50 条

[21] Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial
Heo, Jung-Yoon
Jeon, Hong Jin
Fava, Maurizio
Mischoulon, David
Baer, Lee
Clam, Alisabet
Doorley, James
Pisoni, Angela
Papakostas, George I.
JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 62 : 56 - 61
[22] QUINAPRIL IN HEART INSUFFICIENCY - A DOUBLE-BLIND PLACEBO-CONTROLLED 12-WEEK MULTICENTER STUDY
RIEGGER, AJG
ZEITSCHRIFT FUR KARDIOLOGIE, 1987, 76 : 103 - 103
[23] Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial
Takashi Kadowaki
Masakazu Haneda
Nobuya Inagaki
Yasuo Terauchi
Atsushi Taniguchi
Kazuki Koiwai
Henning Rattunde
Hans J. Woerle
Uli C. Broedl
Advances in Therapy, 2014, 31 : 621 - 638
[24] Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial
Heo, Jung-Yoon
Jeon, Hong Jin
Fava, Maurizio
Mischoulon, David
Baer, Lee
Clain, Alisabet
Doorley, James
Pisoni, Angela
Papakostas, George I.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 102 - 102
[25] Olanzapine for the treatment of borderline personality disorder: Two 12-week randomized double-blind placebo-controlled trials
Zanarini, Mary C.
Schulz, S. Charles
Detke, Holland C.
Tanaka, Yoko
Zhao, Fangyi
Trzaskoma, Quynh
Kryzhanovskaya, Ludmilla
Lin, Daniel
DeBerdt, Walter
Corya, Sara
NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S229 - S230
[26] A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia
Akhondzadeh, Shahin
Gerami, Maryam
Noroozian, Maryam
Karamghadiri, Narges
Ghoreishi, Aboulfazl
Abbasi, Seyed-Hesameddin
Rezazadeh, Sams-Ali
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (08): : 1810 - 1815
[27] Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: A 12-week, double-blind, placebo-controlled trial
Lee, J. G.
Kim, Y. -H.
Lee, S. W.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 141 - 142
[28] Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study
Inagaki, N.
Kondo, K.
Yoshinari, T.
Maruyama, N.
Susuta, Y.
Kuki, H.
DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1136 - 1145
[29] CellCept® (mycopenolate mofetil MMF), a new treatment for RA:: A 12-week, double-blind, randomized, placebo-controlled withdrawal trial.
Schiff, MH
Leishman, B
ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S364 - S364
[30] Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Schoenfeld, Philip
Lacy, Brian E.
Chey, William D.
Lembo, Anthony J.
Kurtz, Caroline B.
Reasner, David S.
Bochenek, Wieslaw
Tripp, Kenneth
Currie, Mark G.
Fox, Susan M.
Blakesley, Rick E.
O'Dea, Christopher R.
Omniewski, Nicholas D.
Hall, Michael L.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (01): : 105 - 114

← 1 2 3 4 5 →